West Pharmaceutical Services (WST) EBT (2016 - 2025)
Historic EBT for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $171.9 million.
- West Pharmaceutical Services' EBT rose 449.85% to $171.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $604.3 million, marking a year-over-year increase of 263.25%. This contributed to the annual value of $585.5 million for FY2024, which is 1611.75% down from last year.
- West Pharmaceutical Services' EBT amounted to $171.9 million in Q3 2025, which was up 449.85% from $157.0 million recorded in Q2 2025.
- Over the past 5 years, West Pharmaceutical Services' EBT peaked at $227.2 million during Q2 2022, and registered a low of $110.5 million during Q1 2025.
- In the last 5 years, West Pharmaceutical Services' EBT had a median value of $168.2 million in 2023 and averaged $165.9 million.
- As far as peak fluctuations go, West Pharmaceutical Services' EBT skyrocketed by 10686.27% in 2021, and later plummeted by 3039.48% in 2024.
- West Pharmaceutical Services' EBT (Quarter) stood at $181.9 million in 2021, then decreased by 29.25% to $128.7 million in 2022, then skyrocketed by 30.69% to $168.2 million in 2023, then decreased by 1.96% to $164.9 million in 2024, then increased by 4.24% to $171.9 million in 2025.
- Its EBT stands at $171.9 million for Q3 2025, versus $157.0 million for Q2 2025 and $110.5 million for Q1 2025.